December 27, 2007
Modified Protein Developed by UC San Diego Researchers May Lead to First Cure for Cirrhosis of the Liver
University of California, San Diego researchers have proven in animal studies that fibrosis in the liver can be not only stopped, but reversed. Their discovery, to be published in PLoS Online on December 26, opens the door to treating and curing conditions that lead to excessive tissue scarring such as viral hepatitis, fatty liver disease, cirrhosis, pulmonary fibrosis, scleroderma and burns.
. . . . . .
_________________________________________________________________